NCT06244849View on ClinicalTrials.gov

TOward a Better Understanding of the autoPhagy Machinery for the Identification of Potential Novel Biomarkers and Therapeutic Targets in Crohn's Disease - TOPIC Study

NANot yet recruitingINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

January 1, 2026

Study Completion Date

January 1, 2026

Conditions
Crohn's Disease
Interventions
BIOLOGICAL

Blood samples

A 28 mL (5 EDTA tubes of 4 mL and 2 dry tubes) venous blood will be collected added to the standard blood analysis performed in routine

BIOLOGICAL

Stool simple

A fresh stool sample will be collected and conserved at room temperature until shipment

BIOLOGICAL

Ileocolonic biopsies

An ileo-colonoscopy with 10 ileal biopsies scheduled in their regular medical follow-up will be performed

Trial Locations (2)

63000

CHU Estaing, Clermont-Ferrand

69495

Centres Hospitalier Lyon Sud, Pierre-Bénite

All Listed Sponsors
collaborator

Centre International de Recherche en Infectiologie (CIRI)

UNKNOWN

lead

Hospices Civils de Lyon

OTHER

NCT06244849 - TOward a Better Understanding of the autoPhagy Machinery for the Identification of Potential Novel Biomarkers and Therapeutic Targets in Crohn's Disease - TOPIC Study | Biotech Hunter | Biotech Hunter